35658630|t|Cerebral small vessel disease and intracranial bleeding risk: Prognostic and practical significance.
35658630|a|Balancing the risks of recurrent ischemia and antithrombotic-associated bleeding, particularly intracranial hemorrhage (ICH), is a key challenge in the secondary prevention of ischemic stroke and transient ischemic attack. In hyperacute ischemic stroke, the use of acute reperfusion therapies is determined by the balance of anticipated benefit and the risk of ICH. Cerebral small vessel disease (CSVD) causes most spontaneous ICH. Here, we review the evidence linking neuroimaging markers of CSVD to antithrombotic and thrombolytic-associated ICH, with emphasis on cerebral microbleeds (CMB). We discuss their role in the prediction of ICH, and practical implications for clinical decision making. Although current observational data suggest CMB presence should not preclude antithrombotic therapy in patients with ischemic stroke or TIA, they are useful for improving ICH risk prediction with potential relevance for determining the optimal secondary prevention strategy, including the use of left atrial appendage occlusion. Following ICH, recommencing antiplatelets is probably safe in most patients, while the inconclusive results of recent randomized controlled trials of anticoagulant use makes recruitment to ongoing trials (including those testing left atrial appendage occlusion) in this area a high priority. Concern regarding CSVD and ICH risk after hyperacute stroke treatment appears to be unjustified in most patients, though some uncertainty remains regarding patients with very high CMB burden and other risk factors for ICH. We encourage careful phenotyping for underlying CSVD in future trials, with the potential to enhance precision medicine in stroke.
35658630	0	29	Cerebral small vessel disease	Disease	MESH:D059345
35658630	34	55	intracranial bleeding	Disease	MESH:D013345
35658630	134	142	ischemia	Disease	MESH:D007511
35658630	173	181	bleeding	Disease	MESH:D006470
35658630	196	219	intracranial hemorrhage	Disease	MESH:D020300
35658630	221	224	ICH	Disease	MESH:D020300
35658630	277	292	ischemic stroke	Disease	MESH:D002544
35658630	297	322	transient ischemic attack	Disease	MESH:D002546
35658630	338	353	ischemic stroke	Disease	MESH:D002544
35658630	462	465	ICH	Disease	MESH:D020300
35658630	467	496	Cerebral small vessel disease	Disease	MESH:D059345
35658630	498	502	CSVD	Disease	MESH:D059345
35658630	528	531	ICH	Disease	MESH:D020300
35658630	594	598	CSVD	Disease	MESH:D059345
35658630	645	648	ICH	Disease	MESH:D020300
35658630	667	687	cerebral microbleeds	Disease	MESH:D002547
35658630	689	692	CMB	Disease	MESH:D002547
35658630	738	741	ICH	Disease	MESH:D020300
35658630	844	847	CMB	Disease	MESH:D002547
35658630	903	911	patients	Species	9606
35658630	917	932	ischemic stroke	Disease	MESH:D002544
35658630	936	939	TIA	Disease	MESH:D002546
35658630	971	974	ICH	Disease	MESH:D020300
35658630	1096	1127	left atrial appendage occlusion	Disease	MESH:D059446
35658630	1139	1142	ICH	Disease	MESH:D020300
35658630	1196	1204	patients	Species	9606
35658630	1358	1389	left atrial appendage occlusion	Disease	MESH:D059446
35658630	1439	1443	CSVD	Disease	MESH:D059345
35658630	1448	1451	ICH	Disease	MESH:D020300
35658630	1474	1480	stroke	Disease	MESH:D020521
35658630	1525	1533	patients	Species	9606
35658630	1577	1585	patients	Species	9606
35658630	1601	1604	CMB	Disease	MESH:D002547
35658630	1639	1642	ICH	Disease	MESH:D020300
35658630	1692	1696	CSVD	Disease	MESH:D059345
35658630	1767	1773	stroke	Disease	MESH:D020521

